Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Repeated dose studies would add nothing to the hazard assessment for this substance, and risk management measures are driven primarily by its corrosive nature due to the high pH. Determination of chronic toxicity is therefore considered inappropriate and unnecessary.


Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
Repeated dose studies would add nothing to the hazard assessment for this substance, and risk management measures are driven primarily by its corrosive nature due to the high pH. Determination of chronic toxicity is therefore considered inappropriate and unnecessary.

Justification for selection of repeated dose toxicity inhalation - systemic effects endpoint:
Repeated dose studies would add nothing to the hazard assessment for this substance, and risk management measures are driven primarily by its corrosive nature due to the high pH. Determination of chronic toxicity is therefore considered inappropriate and unnecessary.

Justification for selection of repeated dose toxicity inhalation - local effects endpoint:
Repeated dose studies would add nothing to the hazard assessment for this substance, and risk management measures are driven primarily by its corrosive nature due to the high pH. Determination of chronic toxicity is therefore considered inappropriate and unnecessary.

Justification for selection of repeated dose toxicity dermal - systemic effects endpoint:
Repeated dose studies would add nothing to the hazard assessment for this substance, and risk management measures are driven primarily by its corrosive nature due to the high pH. Determination of chronic toxicity is therefore considered inappropriate and unnecessary.

Justification for selection of repeated dose toxicity dermal - local effects endpoint:
Repeated dose studies would add nothing to the hazard assessment for this substance, and risk management measures are driven primarily by its corrosive nature due to the high pH. Determination of chronic toxicity is therefore considered inappropriate and unnecessary.

Justification for classification or non-classification

Repeated dose studies would add nothing to the hazard assessment for this substance, and risk management measures are driven primarily by its corrosive nature due to the high pH. Determination of chronic toxicity is therefore considered inappropriate and unnecessary.